<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1049</article-id><article-id pub-id-type="doi">10.36691/RJA1049</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Hyper-IgE syndrome. The history of disease (from Job's syndrome to defect STAT3 gene)</article-title><trans-title-group xml:lang="ru"><trans-title>Гипер-IgE синдром. История болезни (от синдрома Иова до дефекта БТАТЗгена)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yartsev</surname><given-names>Mikhail Nikolaevich</given-names></name><name xml:lang="ru"><surname>Ярцев</surname><given-names>Михаил Николаевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>ФГБУ ГНЦ «Институт иммунологии ФМБА России»</p></bio><email>m_yartsev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Plakhtienko</surname><given-names>M V</given-names></name><name xml:lang="ru"><surname>Плахтиенко</surname><given-names>М В</given-names></name></name-alternatives><bio xml:lang="ru"><p>ФГБУ ГНЦ «Институт иммунологии ФМБА России»</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Yartsev</surname><given-names>M N</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Plahtienko</surname><given-names>M V</given-names></name><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ФГБУ ГНЦ «Институт иммунологии ФМБА России»</institution></aff></aff-alternatives><aff id="aff2"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2009-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2009</year></pub-date><volume>6</volume><issue>4</issue><issue-title xml:lang="en">NO4 (2009)</issue-title><issue-title xml:lang="ru">№4 (2009)</issue-title><fpage>46</fpage><lpage>52</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2009, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2009, Фармарус Принт Медиа</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2011-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/1049">https://rusalljournal.ru/raj/article/view/1049</self-uri><abstract xml:lang="en"><p>The lecture is devoted to hyper-IgE recurrent infections syndrome and is based both upon the literature survey and numerous personal observations for more than 25 years. Initial description of this disease by Davis et al (1966) under the name «Job's syndrome: recurrent «cold» staphylococcal abscesses» was followed by remarkable rinding of Buckley et al (1972) connecting this disease with extreme hyper-immunoglobulinemia E. Later on the two district forms of the disease were described: an autosomal dominant and autosomal recessive. Recently (2007) the nature of the most typical autosomal dominant form of the syndrome was discovered as mutations in STAT3. The discovery explains multiple disorders seen in this multisystem syndrome.</p></abstract><trans-abstract xml:lang="ru"><p>Обобщены материалы зарубежной литературы по истории описания, механизмам развития, особенностям клинической картины аутосомно-доминантного и аутосомно-рецессивного вариантов синдрома гипериммуноглобулинемии Е - повторных инфекций, эффективности проводимой терапии. Представлены обобщенные данные собственных наблюдений за 30-летний период. Отражены современные представления о генетической природе гипер-IgE синдрома, роли STAT3 гена в развитии заболевания.</p></trans-abstract><kwd-group xml:lang="en"><kwd>STAT3</kwd><kwd>hyper-IgE syndrome</kwd><kwd>STAT3</kwd><kwd>primary immunodeficiency</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гипер-IgE синдром</kwd><kwd>первичное иммунодефицитное состояние</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Davis S.D., Schaller J., Wedgwood R.J. Job's syndrome: recurrent, «cold», staphylococcal abscesses. Lancet. 1966, v. 1, p. 1013-1015.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Buckley R.H., Wray B.B., Belmaker E.Z. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972, v. 49, p. 59-70.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hill H.R., Ochs H.D., Quie P.G. et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent «cold» staphylococcal abscesses. Lancet. 1974, v. 2, p. 617-619.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ярцев М.Н., Порховатый С.Я., Гомес Л.А. и cоавт. Клинико-иммунологический полиморфизм синдрома гипериммуноглобулинемии Е. Педиатрия. 1985, № 1, с. 15-18.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ярцев М.Н., Гомес Л.А., Самойленко Е.В., Чебышева Е.В. Гипер-IgE синдром. Критерии диагноза. Вопросы охраны материнства и детства. 1989, № 11, с. 26-30.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Grimbacher B., Holland S.M., Gallin J.I. et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N. Engl. J. Med. 1999, v. 340, p. 692-702.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Freeman A.F., Collura-Burke C.J., Patronas N.J. et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics. 2007, v. 119, p. 1121-1125.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Renner E.D., Puck J.M., Holland S.M. et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J. Pediatr. 2004, v. 144, p. 93-99.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Holland S.M., DeLeo F.R, Elloumi H.Z. et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 2007, v. 357, p. 1608-1619.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hokuto I., Ikegami M., Yoshida M. et al. Stat-3 is required for pulmonary homeostasis during hyperoxia. J. Clin. Invest. 2004, v. 113, p. 28-37.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Welte T., Zhang S.S.M., Wang T. et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc .Natl. Acad. Sci. USA. 2003, v. 100, p. 1879-1884.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Panopoulos A.D., Zhang L., Snow J.W et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood. 2006, v. 108, p. 3682-3690.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Grimbacher B., Holland S.M., Gallin J.I. et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N. Engl. J. Med. 1999, v. 340, p. 692-702.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zhang Z., Welte T., Troiano N. et al. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice. Biochem. Biophys. Res. Commun. 2005, v. 328, p. 800-807.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Freeman A.F, Ling J., Collins M. et al. Minimal trauma fractures and reduced bone mineral density in hyper IgE syndrome. Presented at the Pediatric Academic Societies' Annual Meeting, Toronto, May 5-8, 2007.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Wolk K., Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 2006, v. 17, p. 367-380.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Wolk K., Kunz S., Wtte E. et al. IL-22 increases the innate immunity of tissues. Immunity. 2004, v. 21, p. 241-254.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Jacoby J.J., Kalinowski A, Liu M.-G et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc. Natl. Acad. Sci. USA. 2003, v. 100, p. 12929-12934.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ling J.C, Freeman A.F., Gharib AM. et al. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin. Immunol. 2007, v. 122, p. 255-258.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Okada S., Nakamura M., Katoh H. et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 2006, v. 12, p. 829-834.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Freeman A.F., Collura-Burke C.J., Patronas N.J. et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics. 2007, v. 119, p. 1121-1125.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Wooten D.K., Xie X., Bartos D. et al. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J. Biol. Chem. 2000, v. 275, p. 26566-26575.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Panopoulos A.D., Bartos D., Zhang L., Watowich S.S. Control of myeloid-specific integrin alphaMbeta2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1. J. Biol. Chem. 2002, v. 277, p. 19001-19007.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Wang L., Arcasoy M.O., Watowich S.S., Forget B.G Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells. Exp. Hematol. 2005, v. 33, p. 308-317.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Yang X.O., Panopoulos A.D., Nurieva R. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007, v. 282, p. 9358-9363.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Murray P.J. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 2007, v. 178, p. 2623-2629.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Grimbacher B., Holland S.M., Gallin J.I. et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N. Engl. J. Med. 1999, v. 340, p. 692-702.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Ozaki K., Spolski R., Feng C.G. et al. A critical role for IL-21 in regulating immunoglobulin production. Science. 2002, v. 298, p. 1630-1634.</mixed-citation></ref></ref-list></back></article>
